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Summary
Background: Dengue fever has seen a significant re-emergence in Southeast Asia. Associated with
the rise of dengue has been the increase in dengue-associated mortality. To better understand the
predictors of mortality, we conducted a review of hospitalized adult dengue infections within our
institution.
Methods: This was a retrospective case—control study of dengue-associated deaths at a large
tertiary care hospital.
Results: In 2004, of 3186 cases of dengue fever (DF)/hemorrhagic dengue fever (DHF) admitted
to our institution, there were 130 cases of DHF and seven dengue-associated deaths (case-fatality
rate 5.4%). At least three of the seven fatal cases had serological evidence of primary dengue
infection. All dengue-mortality cases had rapidly progressive clinical deterioration at an average
of day 4 of fever with intensive care admission occurring on a mean of 5.6 days of fever. Adult
respiratory distress syndrome, disseminated intravascular coagulopathy, and multi-organ failure
were the most common causes of death despite early hospitalization, intravenous fluid, and
blood-product support.
Conclusion: Dengue is associated with severe disease, and deaths do occur despite current
supportive management. Fatal DHF/dengue shock syndrome (DSS) does occur in adults and in
primary dengue infection. Better early predictors of disease severity and clinical interventions
are needed.
# 2006 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.Introduction
Dengue virus infection is an important and re-emerging
infection in many parts of the tropics. Southeast Asia in* Corresponding author. Tel.: +65 6357 7925/23;
fax: +65 6252 4056.
E-mail address: aomailbox@gmail.com (A. Ong).
1201-9712/$32.00 # 2006 Published by Elsevier Ltd on behalf of Intern
doi:10.1016/j.ijid.2006.02.012particular has seen large epidemics of the disease in recent
years with attendant mortality from dengue hemorrhagic
fever and dengue shock syndrome. Over 250 000 cases of
dengue hemorrhagic fever, mainly in children, are reported
to the World Health Organization (WHO) annually, with mor-
tality rates of 1—5% among patients with shock.1
In its severest form, dengue virus infection is associated
with hemorrhagic complications, plasma leakage, shock,ational Society for Infectious Diseases.
264 A. Ong et al.liver failure, and disseminated intravascular coagulopathy.2
Unlike the epidemiology of dengue in many developing coun-
tries, the resurgence of dengue in Singapore has been asso-
ciated with an adult predominance with very low incidence in
children.3 Dengue virus infections are rarely fatal in adults,
although fatal infections do occur.4
Since 2003, dengue cases have risen dramatically in Sin-
gapore. In 2004, there was a record 9459 cases notified with
eight deaths, with the highest incidence of disease in young
adults aged 15—24 years.5 More than three quarters of all
dengue cases in Singapore are hospitalized.5 In order to
better understand the risk factors for mortality and the
epidemiology of severe dengue cases in our hospital popula-
tion, we conducted a case—control study of all dengue-
associated deaths within our institution.Methods
A retrospective case—control study was performed. All cases
of dengue-associated mortality in Tan Tock Seng Hospital for
the period 1 January to 31 September 2004 were identified
through cross matching of hospital discharge data with den-Table 1 Admission characteristics of mortality-associated dengu
Variable Mortality-associated
Males (%) 5 (71.4)
Mean age (years) 47
Underlying disease
Diabetes (%) 1 (14.3)
Hypertension (%) 1 (14.3)
Ethnicity
Chinese (%) 4 (57.1)
Malay (%) 2 (28.6)
Indian (%) 1 (14.3)
Others (%) 0
Foreign born (%) 1 (14.3)
Duration of fever (days) 4.8
Primary dengue (%) * 3/4 (75.0)
Minor bleeding (%) 3 (42.9)
Diarrhea (%) 2 (28.6)
Headache (%) 1 (14.3)
Abdominal pain (%) 4 (57.1)
Nausea and vomiting (%) 4 (57.1)
Confusion (%) 2 (28.6)
Rash (%) 0
Heart rate on admission (beats/min) 122
Pulse pressure on admission (mmHg) 47
Platelet count (109 cells/L) 71
Hematocrit (%) 45.6
AST (IU/L) 1293
ALT (IU/L) 309
Albumin (g/L) 32.4
Creatinine (mmol/L) 114
APTT (s) 50.7
PT (s) 18.2
AST, aspartate aminotransferase; ALT, alanine aminotransferase; APTT
* Data not available for all patients.gue notification records. Notification of dengue infection to
the Ministry of Health is mandatory in Singapore. The study
was approved by the institutional review committee of the
National Healthcare Group. Tan Tock Seng Hospital (TTSH) is a
1100-bed tertiary care adult hospital serving the central,
north, and northeastern adult population of Singapore —
areas of known high dengue transmission.5
All cases of dengue were defined as: (i) a compatible
clinical illness with (ii) positive serology (IgM and/or IgG
by Dengue Duo Rapid Strip Test, PanBio, Australia)6 or reverse
transcriptase-polymerase chain reaction (RT-PCR) test. Den-
gue-associated deaths were defined as deaths resulting from,
and as a direct consequence of, acute dengue infection.
Persons admitted with dengue virus infection during the same
month of admission as dengue-associated death cases were
randomly selected from the hospital patient database as
controls. Five controls were chosen for every dengue-asso-
ciated death case. The medical records of all cases identified
were reviewed. Final disease categorization into dengue
fever (DF), dengue hemorrhagic fever (DHF), and dengue
shock syndrome (DSS) was based on the World Health Orga-
nization’s recommended system of classification.7 Day of
illness at admission (day 1 of illness was counted as the daye cases and those with uncomplicated dengue fever
group (n = 7) Uncomplicated DF (n = 35) p
28 (80.0) NS
24 NS
2 (5.7) NS
1 (2.9) NS
NS
30 (85.7)
1 (2.9)
2 (5.7)
2 (5.7)
3 (8.6) NS
4.8 NS
24/31 (77.4) NS
5 (14.3) 0.084
9 (25.7) NS
15 (42.9) NS
13 (37.1) NS
20 (57.1) NS
0 0.019
17 (48.6) 0.039
83 <0.05
49 NS
76 NS
43.8 NS
196 0.015
132 0.075
41.3 <0.05
79 0.008
47.9 NS
12.7 <0.05
, activated partial thromboplastin time; PT, prothrombin time.
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Table 2 Demographic and clinical features of dengue mortality cases
Case Age
(years)/sex
Fever duration prior
to admission (days)
Co-morbidities Dengue tests Clinical course Duration of
hospitalization (days)
Complications/cause of death
1 51/F 3 Diabetes mellitus;
hypertension
IgM pos; IgG neg Admitted in extremis 3 Gastrointestinal bleeding;
ketoacidosis; multi-organ failure
2 31/F 7 Nil IgM pos; IgG neg Rapidly progressive
hypoxemia
and hypotension
4 Acute respiratory distress
syndrome; myocarditis with
cardiogenic shock
3 47/M Unknown Diabetes mellitus IgM pos; IgG neg Acute confusion and
stroke; rapid
deterioration;
prolonged ICU stay
30 Gram-negative septicemia;
acute respiratory distress
syndrome; cerebral infarction;
myocarditis with cardiogenic shock
4 56/M 4 Hyperthyroidism PCR pos Rapid with bleeding
(GI) and shock;
prolonged ICU stay
33 Gastrointestinal bleeding;
acute respiratory distress
syndrome; septicemia;
multi-organ failure
5 52/M 3 Nil PCR pos Rapid with bleeding
(GI) and shock
2 Disseminated intravascular
coagulopathy; multi-organ failure
6 22/M 7 Nil PCR pos Rapid with bleeding
(GI/lung) and shock
2 Severe bilateral pneumonia;
disseminated intravascular
coagulopathy; multi-organ failure
7 71/M Unknown Nil PCR pos;
IgM and IgG pos
Acute stroke with
prolonged ICU stay
22 Acute renal failure; acute
respiratory distress syndrome;
septicemia; multiple
cerebrovascular accidents
ICU, intensive care unit; GI, gastrointestinal.
266 A. Ong et al.of fever onset), demographic, clinical, and laboratory data
were collected on standardized data-collection forms. Pete-
chiae, epistaxis, gingival bleeding, or menorrhagia were clas-
sified as minor bleeding complications.
Statistical analysis
The Student’s t test was used for comparison of continuous
variables, and Fisher’s exact test was used for comparison of
dichotomous variables of mortality-associated dengue cases
and those with uncomplicated DF. For data that were not
normally distributed, the Mann—Whitney U test for contin-
uous values was used. Variables found to be statistically
significant in univariate analyses were entered into multi-
variate analysis using a logistic regression model to identify
independent risk factors for mortality. A two-tailed p value of
<0.05 was considered statistically significant.
Results
A total of 3186 cases of DF/DHFwere admitted to TTSH during
the study period. Of these, 130 (4.1%) were diagnosed with
DHF with seven dengue-associated deaths (case-fatality rate
5.4%).
The admission characteristics of the dengue-associated
death cases compared to controls are shown in Table 1. All
controls were classified as having uncomplicated dengue
fever. Of the dengue-associated death cases, five (71.4%)
were male with a mean age of 47 years (range: 22—71); four
patients (57.1%) were Chinese, two Malay (28.6%), and one
Indian (14.3%). The main presenting complaint in all these
patients was fever; other symptoms included confusion
(28.6%), bleeding manifestations (gum bleeding, hematoche-
zia) (42.9%), nausea and vomiting (57.1%), and abdominal
pain (57.1%). Two patients (patients 3 and 7, Table 2) pre-
sented chiefly with neurological symptoms (localized weak-
ness, confusion) and fever and had initial admitting diagnoses
of cerebrovascular accidents. Two patients (patients 4 and 6)
had fever, abdominal pain, and diarrhea as predominant
symptoms and were admitted initially as infective gastro-
enteritis cases. Patient 1 was diabetic and presented in
ketoacidosis. In four cases (57.1%), prominent abdominal
pain and persistent vomiting preceded hypotension and clin-
ical deterioration. No rash was noted in any of the cases at
presentation. Three patients (42.8%) had pre-existing co-
morbidities including diabetes, hypertension, and hyperthyr-
oidism. The mean number of days of illness prior to hospi-
talization was 4.8.
On admission, all dengue-associated death patients were
febrile (mean 38.7 8C) and tachycardic. Blood pressure was
low (SBP <100 mmHg) in only one patient and all had normal
pulse pressure (>20 mmHg). Laboratory abnormalities on
admission included: thrombocytopenia (71.4%; mean plate-
let count 71  109/L), coagulopathy (42.9%), leukopenia
(28.6%), raised ALT or AST >3 times above normal (85.7%).
Chest X-rays were abnormal in five cases (71.4%) with all
showing bilateral interstitial patterns of disease. Dengue
diagnosis was confirmed by PCR in four patients (serotype
unavailable); dengue serology was performed in four
patients, three with positive IgM alone and one with both
positive IgG and IgM, consistent with primary and secondarydengue infection respectively (Table 2).6 Three patients were
directly admitted to the intensive care unit (ICU). Clinical
deterioration after admission was rapid in all cases and all
patients required eventual transfer to the ICU within a mean
of 2.4 days post-admission and at 5.6 days of fever. Transfer
to the ICU was for hypotension in five patients (71.4%) and
respiratory failure in two (28.6%). All patients received
platelet and/or blood product transfusions. Two patients
had evidence of depressed cardiac function (ejection frac-
tions <30%) on bedside echocardiography. Causes of death in
this series were: multi-organ failure with adult respiratory
distress syndrome (57.1%), pneumonia and/or septicemia
(57.1%), intracerebral hemorrhage (14.3%). No autopsy data
were available.
On univariate analysis, confusion, absence of rash, tachy-
cardia, and abnormalities in liver transaminases, creatinine,
albumin, and prothrombin time were statistically more fre-
quent in mortality-associated cases. On multivariate analy-
sis, only tachycardia on admission was found to be
independently associated with dengue mortality (OR = 3.56,
95% CI = 2.76—4.87, p = 0.036).Discussion
This series of cases serves to characterize the mortality asso-
ciated with adult dengue virus infection during an epidemic
outbreak. Often considered more common in children, DHF is
now being seen more frequently in older adults as a conse-
quence of shifting patterns of infection and immunity.4,8,9
Although the pathogenesis and pathophysiology of severe
dengue infections remains incompletely understood, possible
contributory factors to increased disease severity have been
described. Age,10 sex,4 race,11 pre-existing co-morbidities,12
and viral-specific features13 have been noted to play a role in
disease outcomes by various authors. Vaughn and colleagues
have previously shown that disease severity correlates to high
dengue viremia titers and secondary infections.14
It is postulated that the sequence of infecting dengue virus
serotypes may be significant with respect to the risk of
developing DHF and more severe disease,15,16 though all four
dengue serotypes can cause DHF.17 In 2003, DEN-2 was the
predominant circulating strain in Singapore (80% of serotypes
detected; overall dengue incidence 108.5 per 100 000 with
six deaths);5 however 2004 saw the introduction of DEN-1 as
the major serotype and a resurgence of dengue (67% of
circulating strains tested; overall dengue incidence 223
per 100 000 with eight deaths).18 It is possible that this
change in the predominant dengue strain and/or sequence
of infections contributed towards the increase in DHF and
more severe outcomes seen, though this remains unproven.
Further, at least three of the fatal cases in this series had
evidence of primary dengue infection on serology. This is in
contrast to other reports that have described mortality and
severe disease occurring predominantly in secondary infec-
tion.4,11,16,19
The mortality rate in cases complicated by hemorrhage is
three to four times greater than that in thosewithout bleeding
manifestations.7 Mortality is usually linked to delayed provi-
sion of supportive treatment and/or pre-morbid chronic ill-
ness.7 In this series, thoughtheaveragedurationof illnessprior
to admission and presence of co-morbidities was not signifi-
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course or presented at a far advanced stage of illness. Clinical
deterioration occurred on average at day 4 with patients
entering the intensive care unit at a mean of day 5.6 of fever.
This clinical course is similar to that classically described in
DHF/DSS7,19 and inother series onadult denguemortality.4,8,20
Although good early predictors of severity are presently
lacking, warning symptoms such as abdominal pain and
vomiting were noted in the majority of the severe cases
prior to clinical deterioration. This is a well-recognized
feature of severe plasma leakage and impending shock and
when it occurs around the period of fever defervescence,
should prompt closer monitoring and treatment.7 Further,
the prolongation of prothrombin time (PT) seen in mortality-
associated cases in this series is consistent with the coagulo-
pathy and abnormalities in the tissue-factor pathway seen in
severe dengue cases21—23 and should warrant prompt correc-
tion and support. Autopsy studies demonstrate that patients
who succumb to DHF do so from acute physiologic reactions
caused by vascular permeability and inflammation.20,24 The
mainstay of treatment remains prompt fluid resuscitation to
counteract massive plasma leakage. Timely and effective
intravenous crystalloid replacement of plasma losses results
in a favorable outcome in most cases.25,26 Reversing shock
and electrolyte abnormalities help prevent the onset of
disseminated intravascular coagulation.7 However the use
of preventive blood transfusion in DHF/DSS especially during
the plasma leakage phase may be deleterious27 and might
contribute to increased incidence of pulmonary edema and
congestive heart failure. Its routine role in the clinical
management of severe dengue infection merits further study
and review.
As this series demonstrates, fatal DHF/DSS does occur in
adults and in primary dengue infection. Aminority of patients
will still progress into fatal DHF/DSS and intractable coagulo-
pathy despite receipt of current supportive measures, high-
lighting the need for improved clinical interventions and
early predictors of disease severity.
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